重症监护室获得的弱点是可修改的器官功能障碍吗? 对不断发展的诊断和治疗概念进行叙述性审查
Moritz L Schmidbauer1, Konstantinos Dimitriadis1
1Department of Neurology, University Hospital LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Nutrients
|March 14, 2026
概括
重症监护室获得的软弱 (ICUAW) 在严重疾病中很常见,导致结果不佳. 早期动员和神经肌肉电刺激对管理这种情况有希望.
科学领域:
- 关键护理医学 关键护理医学
- 神经学 神经学
- 康复医学 康复医学 康复医学
背景情况:
- 重症监护室获得的虚弱 (ICUAW) 影响高危危重症患者的高达80%.
- ICUAW与延长通风,延长住院时间,增加死亡率和长期残疾有关.
- 它呈现为四重症,具有异质的病理生理学,分类为危急疾病多神经病变 (CIP),肌病 (CIM) 和多神经肌病 (CIPNM).
研究的目的:
- 审查ICUAW的流行,影响,诊断和管理.
- 突出了对ICUAW的精细定义和向治疗的需要.
- 强调多式联络策略和长期跟踪对改善患者治疗结果的重要性.
主要方法:
- 关于ICUAW流行,临床定义,诊断工具和治疗策略的文献综述.
- 分析目前的预防措施,重点关注代谢因素和非药物干预措施.
- 讨论病理生物学异质性和需要生物学上精细的定义.
主要成果:
- ICUAW是一种严重的并发症,与严重的患者结局和高的医疗保健成本有关.
- 诊断依赖于MRC总分 (<48),附加电生理学研究的效用有限.
- 预防策略包括优化营养和避免过度养;早期动员和神经肌肉电刺激是有希望的非药物治疗方法.
结论:
- ICUAW的多因素性质需要一个生物精细的定义来指导向治疗.
- 在后重症监护综合征 (PICS) 诊所中,全面的多式联络管理和结构化的随访至关重要.
- 改善ICUAW的结果需要在预防,诊断和康复方面采取协调一致的努力.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Acute Kidney Injury I: Introduction
1.5K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.5K
Acute Kidney Injury II: Pathophysiology
2.4K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.4K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
582
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
582
Acute Kidney Injury VI: Nursing Management
814
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
814
Myasthenia Gravis ll: Pathophysiology
69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69


